Objective: Spinal cord stimulation (SCS) is widely used to treat neuropathic pain. Burst SCS, an alternative mode of stimulation, reduces neuropathic pain without paresthesia. However, the effects and mechanisms of burst SCS have not been compared to conventional tonic SCS in controlled investigations. This study compares the attenuation of spinal neuronal activity and tactile allodynia, and the role of γ-aminobutyric acid (GABA) signaling during burst or tonic SCS in a rat model of cervical radiculopathy.
Methods: The effects of burst and tonic SCS were compared by recording neuronal firing before and after each mode of stimulation at day 7 following a painful cervical nerve root compression. Neuronal firing was also recorded before and after burst and tonic SCS in the presence of the GABAB receptor antagonist, CGP35348.
Results: Burst and tonic SCS both reduce neuronal firing. The effect of tonic SCS, but not burst SCS, is blocked by CGP35348. In a separate study, spinal cord stimulators were implanted to deliver burst or tonic SCS beginning on day 4 after painful nerve root compression; allodynia and serum GABA concentration were measured through day 14. Burst and tonic SCS both reduce allodynia. Tonic SCS attenuates injury-induced decreases in serum GABA, but GABA remains decreased from baseline during burst SCS.
Conclusion And Significance: Together, these studies suggest that burst SCS does not act via spinal GABAergic mechanisms, despite its attenuation of spinal hyperexcitability and allodynia similar to that of tonic SCS; understanding other potential spinal inhibitory mechanisms may lead to enhanced analgesia during burst stimulation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1109/TBME.2015.2399374 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Long-Term Effects of Spinal Cord Stimulation on Pain in Postherpetic Neuralgia.
Stereotact Funct Neurosurg
November 2024
Department of Neurosurgery, University of Illinois at Chicago, Chicago, Illinois, USA.
Introduction: Postherpetic neuralgia (PHN) is a pain syndrome that develops within few months after the acute herpetic outbreak. The pain may be accompanied by specific cutaneous signs in the distribution of affected dermatomes and feel unbearable reaching up to 9-10/10 on visual analog scale (VAS). Despite the introduction of new medications, drug resistance develops in at least 50% of cases.
View Article and Find Full Text PDFA Late Complication Related to Percutaneous Implantable Leads for Spinal Cord Stimulation: Myelopathy due to Fibrous Scar Tissue.
NMC Case Rep J
October 2024
Department of Neurosurgery, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.
Article Synopsis
- - A 59-year-old woman developed complex regional pain syndrome in her right arm after surgery for cubital tunnel syndrome, leading to treatment with spinal cord stimulation (SCS) that initially helped her pain.
- - Four years later, she experienced motor weakness on her left side and reduced effectiveness of the SCS therapy, which prompted an MRI revealing significant compression of her cervical spinal cord due to epidural granulation tissue.
- - After surgically removing the granulation tissue, her motor weakness improved, and histological tests indicated that an allergic reaction to materials in the SCS setup caused the tissue fibrosis.
Unaltered Responses of Distal Motor Neurons to Non-Targeted Thoracic Spinal Cord Stimulation in Chronic Pain Patients.
Pain Ther
December 2024
Division of Functional Neurosurgery and Stereotaxy, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Erlangen, Germany.
Introduction: Spinal cord stimulation (SCS) represents an established interventional pain therapeutic; however, the SCS effects of SCS waveforms on motor neuron recruitment of the lower limbs of chronic pain patients remain largely unknown.
Methods: We investigated these effects by performing isometric ankle-dorsal flexions at varying force levels under four SCS conditions: SCS Off (1 week), burst SCS (40 Hz), SCS Off (acute), and tonic SCS (130 Hz). Muscle activity was recorded via high-density surface electromyography (64-electrode grid) on the tibialis anterior muscle.
Multidevice spinal cord stimulation trials: shared decision making in the era of multiple neuromodulation paradigms.
Pain Manag
October 2024
University of Rochester Medical Center, Department of Anesthesiology & Perioperative Medicine, 601 Elmwood Ave, Rochester, NY 14642, USA.
There is a lack of evidence-based standards for matching spinal cord stimulation (SCS) paradigm to individual patients. We aim to determine the feasibility and safety of a new alternative trial strategy, a sequential multidevice trial. A retrospective analysis was performed on 116 patients who underwent SCS trials, single device or sequential multidevice (tonic and high-frequency), for chronic low back pain to assess feasibility and compare trial-to-implantation rate and explantation rate.
View Article and Find Full Text PDFPsychophysical and Functional Outcomes in Chemotherapy-induced Peripheral Neuropathy After Spinal Cord Stimulation: A Narrative Review and Case Series.
Neuromodulation
December 2024
Division of Anesthesiology, Critical Care & Pain Medicine, Department of Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Article Synopsis
- Chemotherapy-induced peripheral neuropathy (CIPN) can occur after cancer treatment, and spinal cord stimulation (SCS) is being explored for treating severe cases.
- A study examined the effectiveness of two types of SCS (tonic vs. burst) in improving pain and gait in patients with CIPN, alongside quantitative sensory testing (QST) outcomes.
- Results showed improvements in gait scores and pain relief, although some sensory testing outcomes were inconsistent; the study highlights the potential of different SCS waveforms in managing CIPN and emphasizes the importance of psychophysical testing as a monitoring tool.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!